Product NewsACE BioSciences’ Lead Product, The World’s First Commercial Vaccine For Travellers’ Diarrhoea Caused By Campylobacter, Enters Clinical Trials On Schedule
Product NewsTissue specific optimized AAV Plasmids are now available to make research & therapy more targeted